Bromide

Bromide

SCHEMBL5154869

Br.Br.Br.Br.[P]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1856 1.00
Bromide SCHEMBL11224381 1.00
Bromide SCHEMBL82194 1.00
Bromide SCHEMBL312889 1.00
Bromide SCHEMBL6294269 1.00
Bromide SCHEMBL10784827 0.82
Bromide SCHEMBL3326847 0.82
Bromide SCHEMBL11116971 0.82
Bromide SCHEMBL11404944 0.82
Bromide SCHEMBL11418208 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-6080647-A None JP disclosed
WO-2020235968-A1 ELECTROLYTE ADDITIVE FOR SECONDARY BATTERY, PREPARATION METHOD THEREFOR, AND ELECTROLYTE COMPOSITION AND SECONDARY BATTERY, WHICH COMPRISE ADDITIVE (주)후성 (KR) 2020-11-26 WO disclosed
US-7189873-B2 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms SYNGENTA CORP PROTECTION, INC. (US) 2007-03-13 US disclosed
EP-1549609-B1 PROPARGYLETHER DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE FOR CONTROLLING PHYTOPATHOGENIC MICROORGANISMS SYNGENTA PARTICIPATIONS AG (CH) 2007-01-24 EP disclosed
US-20060167316-A1 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms SYNGENTA CROP PROTECTION, INC. 2006-07-27 US disclosed
EP-1549609-A2 PROPARGYLETHER DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE FOR CONTROLLING PHYTOPATHOGENIC MICROORGANISMS Syngenta Participations AG (CH) 2005-07-06 EP disclosed
WO-2004033413-A2 PROPARGYLETHER DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE FOR CONTROLLING PHYTOPATHOGENIC MICROORGANISMS SYNGENTA PARTICIPATIONS AG (CH) 2004-04-22 WO disclosed
EP-0724586-B1 PROCESS FOR PREPARING N-(2,6-DICHLORO-3-METHYLPHENYL)-5-7-DIHALO[1,2,4]TRIAZOLO[1,5A]PYRIMIDINE-2-SULFONAMIDE BY CYCLIZATION AND HALO-DEHYDROXYLATION DOW AGROSCIENCES LLC (US) 2002-01-23 EP disclosed
US-6248919-B1 E.G., (2S)-2-(((5-((BUTYL(2-CYCLOHEXYLETHYL)AMINO)METHYL) -2'-METHYL(1,1'-BIPHENYL)-2-YL)CARBONYL)AMINO)-4-(METHYLSULFAN YL)BUTANOIC ACID, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR PRODRUG THEREOF. ABBOTT LABORATORIES 2001-06-19 US disclosed
US-5703258-A FLAME RETARDERS BLOUNT DAVID H (US) 1997-12-30 US disclosed
JP-H0680647-A NEW QUINAZOLINE DERIVATIVE HISAMITSU PHARMACEUT CO INC 1994-03-22 JP disclosed